Accuracy, Feasibility and Acceptance of CGM Lupus
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03296995|
Recruitment Status : Recruiting
First Posted : September 29, 2017
Last Update Posted : September 29, 2017
|Condition or disease||Intervention/treatment||Phase|
|Systemic Lupus Erythematosus Critical Illness Diabetic Blood Glucose Monitoring||Device: Flash glucose monitoring system||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Accuracy, Feasibility and Acceptance of Continuous Glucose Monitoring in Critically Systemic Lupus Erythematosus|
|Actual Study Start Date :||July 1, 2017|
|Estimated Primary Completion Date :||October 1, 2018|
|Estimated Study Completion Date :||October 1, 2019|
Experimental: flash glucose monitoring system
Subjects in the arm measure blood glucose by flash glucose monitoring system.
Device: Flash glucose monitoring system
Flash glucose monitoring systems in critically ill patients may improve glycemic control and reduce glucose variability.
- Accuracy of continuous glucose monitoring compared to glucose oxidase method [ Time Frame: 7 d ]Difference between glucose values of continuous glucose monitoring and blood gas analyses
- Feasibility of continuous glucose monitoring [ Time Frame: 7 d ]Problems within the application of sensor and monitoring during ward routine
- Acceptance of continuous glucose monitoring by physicians and nursing staff [ Time Frame: 7 d ]Acceptance and evaluation of the device by physicians and nursing staff evaluated by questionnaire
- Technical problems with the monitoring [ Time Frame: 7 d ]Number of needed sensors per patient. Duration of functional sensor. Number and reasons for accidentally sensor removal.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03296995
|Shuang Ye, MD||Recruiting|
|Shanghai, Shanghai, China|
|Contact: Shuang Ye, MD +8613817615871 firstname.lastname@example.org|
|Contact: Huijing Wang, postgraduate +8618267851823 email@example.com|